Health and Economic Impact of Atrial Fibrillation of Workers in Italy: Social Security Benefits.
atrial fibrillation
healthcare costs
medico-legal evaluation
occupational health
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
08 02 2022
08 02 2022
Historique:
received:
29
12
2021
revised:
04
02
2022
accepted:
06
02
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
1
3
2022
Statut:
epublish
Résumé
The aim of this research was to analyze trends in social security applications in Italy as a result of the onset of atrial fibrillation, analyzing data pertaining to the classification of professions and assessing the economic impact on the social security system. We analyzed all applications for invalidity allowances and invalidity pensions throughout Italy over a 10-year period from 01.01.2009 to 31.12.2019, giving specific attention to all reports indicating atrial fibrillation as the principal diagnosis (Cod. ICD-9-CM 427.31). We then extracted the relative expenditure data for said benefits. The results of all analyses have been collated in tables. Over the period in question, a total of 3468 applications for assistance were filed throughout Italy indicating a diagnosis of atrial fibrillation, of which 58% were rejected, 41% qualified for an invalidity allowance, and only 1.1% qualified for a pension. On average, every year, 1100 workers received social security benefits as a result of a diagnosis of atrial fibrillation, which equates to an average annual expenditure of EUR 10 million. A comparison of the data from the first observation year (2009) with data from the last (2019) shows a rising trend in the number of beneficiaries and consequently in expenses. The social security assistance provided by the Italian government by means of the National Institute of Social Security is fundamental to social cohesion and to those who are either permanently disabled from working or those with a significantly diminished earning capacity. This assistance is associated with a significant financial cost, which requires careful monitoring.
Sections du résumé
BACKGROUND
The aim of this research was to analyze trends in social security applications in Italy as a result of the onset of atrial fibrillation, analyzing data pertaining to the classification of professions and assessing the economic impact on the social security system.
METHODS
We analyzed all applications for invalidity allowances and invalidity pensions throughout Italy over a 10-year period from 01.01.2009 to 31.12.2019, giving specific attention to all reports indicating atrial fibrillation as the principal diagnosis (Cod. ICD-9-CM 427.31). We then extracted the relative expenditure data for said benefits. The results of all analyses have been collated in tables.
RESULTS
Over the period in question, a total of 3468 applications for assistance were filed throughout Italy indicating a diagnosis of atrial fibrillation, of which 58% were rejected, 41% qualified for an invalidity allowance, and only 1.1% qualified for a pension. On average, every year, 1100 workers received social security benefits as a result of a diagnosis of atrial fibrillation, which equates to an average annual expenditure of EUR 10 million. A comparison of the data from the first observation year (2009) with data from the last (2019) shows a rising trend in the number of beneficiaries and consequently in expenses.
CONCLUSIONS
The social security assistance provided by the Italian government by means of the National Institute of Social Security is fundamental to social cohesion and to those who are either permanently disabled from working or those with a significantly diminished earning capacity. This assistance is associated with a significant financial cost, which requires careful monitoring.
Identifiants
pubmed: 35162904
pii: ijerph19031883
doi: 10.3390/ijerph19031883
pmc: PMC8834668
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Eur J Prev Cardiol. 2018 Jul;25(11):1140-1141
pubmed: 29929391
Ann Intern Med. 2017 Mar 7;166(5):ITC33-ITC48
pubmed: 28265666
J Occup Health. 2021 Jan;63(1):e12204
pubmed: 33556993
Ther Adv Drug Saf. 2017 Feb;8(2):67-75
pubmed: 28255434
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Curr Pharm Biotechnol. 2021;22(15):1994-2000
pubmed: 33308127
Clin Cardiol. 2012 Jan;35 Suppl 1:1-2
pubmed: 22246945
Reumatismo. 2015 Sep 16;67(2):45-56
pubmed: 26492962
Lancet. 2015 Oct 31;386(10005):1739-46
pubmed: 26298822
Acta Clin Belg. 2014 Dec;69(6):407-11
pubmed: 25176558
Medicina (Kaunas). 2020 May 10;56(5):
pubmed: 32397581
Br Med J. 1968 Jan 13;1(5584):75-9
pubmed: 5634717
Int J Environ Res Public Health. 2020 Oct 30;17(21):
pubmed: 33143150
J Cardiovasc Med (Hagerstown). 2014 Mar;15(3):235-53
pubmed: 23114271
J Occup Health. 2019 Nov;61(6):431-441
pubmed: 31237053
Int J Environ Res Public Health. 2020 Dec 05;17(23):
pubmed: 33291364